PHAT (Phathom Pharmaceuticals) Inventories, Finished Goods: $1.5 Mil (As of Mar. 2026)


PHAT Phathom Pharmaceuticals Inc PHAT
23 GF Score
Price $11.21
! 3 Warning Signs
View Full Analysis

What is Phathom Pharmaceuticals Inventories, Finished Goods?

Phathom Pharmaceuticals PHAT +6.21% 23 Inventories, Finished Goods is $1.5 Mil as of Mar. 2026. GuruFocus rates PHAT with a GF Score™ of 23/100. The stock has 3 warning signs investors should review.

Phathom Pharmaceuticals's quarterly finished goods declined from Sep. 2025 ($2.6 Mil) to Dec. 2025 ($1.5 Mil) but then increased from Dec. 2025 ($1.5 Mil) to Mar. 2026 ($1.5 Mil).

Phathom Pharmaceuticals's annual finished goods increased from Dec. 2023 ($0.6 Mil) to Dec. 2024 ($1.5 Mil) but then declined from Dec. 2024 ($1.5 Mil) to Dec. 2025 ($1.5 Mil).

Phathom Pharmaceuticals Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Phathom Pharmaceuticals's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phathom Pharmaceuticals Inventories, Finished Goods Chart

Phathom Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial 0.00 0.00 0.65 1.48 1.46

Phathom Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.73 2.44 2.60 1.46 1.48
PHAT
23GF Score
Phathom Pharmaceuticals Inc PHAT
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Phathom Pharmaceuticals Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of $1.5 Mil mean?
Phathom Pharmaceuticals (PHAT) has a Inventories, Finished Goods of $1.5 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Phathom Pharmaceuticals and its competitors.
Is Phathom Pharmaceuticals' Inventories, Finished Goods too high?
Phathom Pharmaceuticals' current Inventories, Finished Goods is $1.5 Mil. Overall, Phathom Pharmaceuticals has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Phathom Pharmaceuticals' Inventories, Finished Goods compare to GERN and ODTX?
Phathom Pharmaceuticals' Inventories, Finished Goods of $1.5 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Biotechnology company?
A good Inventories, Finished Goods depends on the Biotechnology industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Phathom Pharmaceuticals and its competitors. Phathom Pharmaceuticals's current Inventories, Finished Goods is $1.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phathom Pharmaceuticals stock overvalued right now?
Phathom Pharmaceuticals (PHAT) has a current Inventories, Finished Goods of $1.5 Mil. The current Inventories, Finished Goods is $1.5 Mil. Phathom Pharmaceuticals' overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Phathom Pharmaceuticals (PHAT), the current Inventories, Finished Goods is $1.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Phathom Pharmaceuticals Business Description

Address 100 Campus Drive, Suite 102, Florham Park, NJ, USA, 07932
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
23GF Score

Get the complete analysis for PHAT

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.21
Price